Germline RUNX1 mutations cause Familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by an increased risk of developing hematologic malignancies. Here, RUNX1 is linked to hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1.